Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001104659-26-120789

Director bought 969,480 shares at $21.00 ($20,359,080)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HEALY JAMES Director 2026-10-28 Purchase +952,380 $21.00 $19,999,980 2,815,707 I
HEALY JAMES Director 2026-10-28 Purchase +6,395 $21.00 $134,295 17,990 I
HEALY JAMES Director 2026-10-28 Purchase +3,772 $21.00 $79,212 14,924 I
HEALY JAMES Director 2026-10-28 Purchase +6,933 $21.00 $145,593 25,267 I
Open-market purchases · 969,480 sh · avg $21.00 · $20,359,080
Loading xslF345X06/tm2628672-1_4seq1.xml…